CG
PBYI icon

Cutler Group’s Puma Biotechnology PBYI Stock Holding History

Cutler Group’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-200
Closed – – 4151
2023
Q3 		$0 Hold
200
– – ﹤0.01% 4190
2023
Q2 		$0 Hold
200
– – ﹤0.01% 4024
2023
Q1 		$0 Hold
200
– – ﹤0.01% 4477
2022
Q4 		$0 Hold
200
– – ﹤0.01% 4992
2022
Q3 		$0 Hold
200
– – ﹤0.01% 5344
2022
Q2 		$0 Hold
200
– – ﹤0.01% 5484
2022
Q1 		$0 Hold
200
– – ﹤0.01% 5838
2021
Q4 		$0 Hold
200
– – ﹤0.01% 5872
2021
Q3 		$1K Hold
200
– – ﹤0.01% 5376
2021
Q2 		$1K Hold
200
– – ﹤0.01% 5380
2021
Q1 		$1K Sell
200
-600
-75% -$6.7K ﹤0.01% 5313
2020
Q4 		$8K Hold
800
– – ﹤0.01% 3357
2020
Q3 		$8K Buy
800
+200
+33% +$2.04K ﹤0.01% 3160
2020
Q2 		$6K Sell
600
-1,450
-71% -$15K ﹤0.01% 3209
2020
Q1 		$17K Buy
2,050
+750
+58% +$7.29K ﹤0.01% 2409
2019
Q4 		$11K Buy
1,300
+300
+30% +$2.48K ﹤0.01% 2596
2019
Q3 		$10K Sell
1,000
-4,500
-82% -$48.6K ﹤0.01% 2634
2019
Q2 		$69K Buy
5,500
+1,720
+46% +$39.6K 0.01% 1319
2019
Q1 		$146K Sell
3,780
-397
-10% -$12.1K 0.02% 802
2018
Q4 		$85K Sell
4,177
-15,074
-78% -$452K 0.01% 1137
2018
Q3 		$882K Buy
19,251
+3,804
+25% +$183K 0.06% 304
2018
Q2 		$913K Buy
15,447
+10,810
+233% +$626K 0.07% 282
2018
Q1 		$315K Sell
4,637
-16,703
-78% -$1.25M 0.03% 594
2017
Q4 		$2.11M Buy
21,340
+9,764
+84% +$1.09M 0.09% 160
2017
Q3 		$1.39M Sell
11,576
-36,197
-76% -$3.37M 0.05% 269
2017
Q2 		$4.17M Buy
47,773
+37,067
+346% +$2.07M 0.15% 110
2017
Q1 		$398K Sell
10,706
-16,440
-61% -$600K 0.02% 753
2016
Q4 		$833K Buy
27,146
+26,212
+2,806% +$1.13M 0.03% 476
2016
Q3 		$62K Sell
934
-8,032
-90% -$406K ﹤0.01% 2244
2016
Q2 		$267K Sell
8,966
-12,027
-57% -$376K 0.01% 922
2016
Q1 		$616K Buy
20,993
+13,812
+192% +$624K 0.04% 435
2015
Q4 		$562K Buy
+7,181
New +$564K 0.03% 562

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $783M AUM 81.58% 1-Year Est. Return

Cutler Group's PBYI Position: Q4 2023 in Review

Cutler Group sold out of Puma Biotechnology (PBYI) in Q4 2023, closing a stake of 200 shares.

Cutler Group first reported a position in PBYI in Q4 2015 and held it in 32 quarters. The position peaked at $4.17M in Q2 2017. 82 funds tracked by Wall St. Rank hold PBYI as of Q4 2023.

  • Cutler Group reported no remaining Puma Biotechnology position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 200 Puma Biotechnology shares in Q4 2023.
  • Cutler Group first reported a position in Puma Biotechnology in Q4 2015 and held it in 32 quarters.
  • Cutler Group's Puma Biotechnology position peaked at $4.17M in Q2 2017.
  • 82 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.